Drug Pipeline

Trabectedin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 2/3
1
Phase 2
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT05432791 Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma… Locally Advanced Uterine Corpus Leiomyosarcoma Active, Not Recruiting
Phase 2
NCT07076186 Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy… Uterine Leiomyosarcoma Recruiting
NCT04383119 Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma Leiomyosarcoma of Ovary Recruiting
NCT04305548 Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma Mesenchymal Chondrosarcoma Recruiting
Phase 1
NCT07444619 A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab… Soft Tissue Sarcomas Not Yet Recruiting
Sponsors Running Trabectedin Trials
Disease Areas
Get alerts when Trabectedin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free